Vivo Heart: Home-Based Virtual Exercise Program for Older Adults With Cardiovascular Disease
2 other identifiers
interventional
27
1 country
1
Brief Summary
This pilot study will assess the feasibility and generate preliminary efficacy data of a novel, synchronous, home-based exercise training program for rural older adults with cardiovascular disease (CVD) using Vivo, an online, live, small group fitness program developed for older adults. It uses individually tailored dual-tasked (i.e., cognitive-motor) exercises to improve strength, endurance, balance, and cognition and incorporates social engagement. Certified trainers deliver instruction and coaching through an interactive session (45 min, 2-3 times/week) delivered over 12 weeks. Vivo Heart adapts this unique program to meet the cardiac rehabilitation needs of older adults with CVD. The specific aims are to evaluate the feasibility, acceptability, and uptake of Vivo Heart (Aim 1) and obtain pre- and post-intervention measures of exercise capacity, strength, lower-extremity physical function, cognition, quality of life, stress, fatigability, physical activity, and aging biomarkers (Aim 2).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2023
CompletedFirst Posted
Study publicly available on registry
August 2, 2023
CompletedStudy Start
First participant enrolled
March 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 16, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 16, 2025
CompletedJune 4, 2025
May 1, 2025
1.2 years
July 25, 2023
May 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Completion Rate
Completion rate which will be determined by the percentage of enrolled participants who complete the study with ≥80% compliance.
Week 12
Secondary Outcomes (6)
Recruitment Rate
Year 1
Recruitment Yield
Year 1
Compliance Rate
Week 12
Retention Rate
Week 12
Satisfaction Survey Scores
Week 12
- +1 more secondary outcomes
Other Outcomes (15)
VO2 peak
Week 12
Montreal Cognitive Assessment (MoCA)
Week 12
Digit Symbol Coding (DSC)
Week 12
- +12 more other outcomes
Study Arms (1)
Vivo Heart
EXPERIMENTALThis virtual intervention will include weekly group exercise sessions with a Vivo trainer (2 times/week), weekly health education classes with a registered dietitian (RD) (1 time/week), and two individual meetings with the RD over the course of 12 weeks. Participants will also be asked to complete a weekly aerobic exercise session on their own (1 time/week).
Interventions
Vivo is an online, live, small group fitness program developed for older adults that uses individually tailored dual-tasked (i.e., cognitive-motor) exercises to improve strength, endurance, balance, and cognition and incorporates social engagement. Certified trainers deliver instruction and coaching through an interactive session for 45 min, 2-3 times/week.
Eligibility Criteria
You may qualify if:
- years
- Lives in a rural area based on established urban-rural definitions (e.g., RUCA codes, RUCC, UIC)
- A qualifying Cardio Vascular Disease (CVD) event or procedure
- Cognitively unimpaired Telephone Interview for Cognitive Status (TICS-m ≥32)
- No major depressive symptoms Patient Health Questionnaire (PHQ-8 \<10)
- Ambulatory and community-dwelling
- Less than 150 min per week of moderate-to-intensive aerobic or resistance exercise in the past month
- Medically cleared for exercise if event was within the last 6 months
- Access to a tablet or computer and internet/Wi-Fi in defined exercise space
- Able to provide own transportation to study visits
- Not participating in a clinical trial
- Willing to provide informed consent
You may not qualify if:
- \<60 years or \>80 years
- Lives in non-rural area
- No CVD or a qualifying event or procedure
- Dementia or severe cognitive impairment (TICS-m \<32)
- Clinical depression (PHQ-8 ≥10)
- Non-ambulatory, institutionalized, or requires walker
- Regular aerobic or resistance exercise (including current participation in a cardiac rehab program)
- Not medically cleared for exercise
- Advanced kidney disease requiring dialysis or dialysis anticipated within 6 months
- Insulin-dependent diabetes
- Use of any supplemental oxygen for COPD
- Significant impairment from a prior stroke
- Progressive neurologic disease (Parkinson's, ALS, multiple sclerosis, Alzheimer's disease, dementia)
- Severe arthritis, fracture, chronic injury, or other musculoskeletal disorder that prevents walking independently
- Cancer (not including non-melanoma skin cancers) requiring treatment with the past year
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Tina E Brinkley, PhD
Wake Forest University Health Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2023
First Posted
August 2, 2023
Study Start
March 19, 2024
Primary Completion
May 16, 2025
Study Completion
May 16, 2025
Last Updated
June 4, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share